These antifibrotic effects are in consonance with other NAFLD/NASH studies where NR treatment prevented the abnormal expression of hepatic Col1α1 and reduced Masson’s trichome staining in liver sections [65,83]. This evidence concerns the gene COL1A1 and metabolic dysfunction-associated steatotic liver disease.